United Therapeutics Statistics
Total Valuation
UTHR has a market cap or net worth of $12.94 billion. The enterprise value is $8.11 billion.
| Market Cap | 12.94B |
| Enterprise Value | 8.11B |
Important Dates
The next estimated earnings date is Wednesday, July 30, 2025, before market open.
| Earnings Date | Jul 30, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
UTHR has 45.11 million shares outstanding. The number of shares has decreased by -3.02% in one year.
| Current Share Class | 45.11M |
| Shares Outstanding | 45.11M |
| Shares Change (YoY) | -3.02% |
| Shares Change (QoQ) | -0.21% |
| Owned by Insiders (%) | 1.74% |
| Owned by Institutions (%) | 95.61% |
| Float | 41.60M |
Valuation Ratios
The trailing PE ratio is 11.43 and the forward PE ratio is 10.19. UTHR's PEG ratio is 2.01.
| PE Ratio | 11.43 |
| Forward PE | 10.19 |
| PS Ratio | 4.28 |
| Forward PS | 3.88 |
| PB Ratio | 1.90 |
| P/TBV Ratio | 1.93 |
| P/FCF Ratio | 11.47 |
| P/OCF Ratio | 9.17 |
| PEG Ratio | 2.01 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 5.21, with an EV/FCF ratio of 7.18.
| EV / Earnings | 6.70 |
| EV / Sales | 2.71 |
| EV / EBITDA | 5.21 |
| EV / EBIT | 5.49 |
| EV / FCF | 7.18 |
Financial Position
The company has a current ratio of 5.46, with a Debt / Equity ratio of 0.03.
| Current Ratio | 5.46 |
| Quick Ratio | 5.05 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | 0.13 |
| Debt / FCF | 0.18 |
| Interest Coverage | 41.39 |
Financial Efficiency
Return on equity (ROE) is 19.94% and return on invested capital (ROIC) is 14.27%.
| Return on Equity (ROE) | 19.94% |
| Return on Assets (ROA) | 12.97% |
| Return on Invested Capital (ROIC) | 14.27% |
| Return on Capital Employed (ROCE) | 21.04% |
| Revenue Per Employee | $230.32M |
| Profits Per Employee | $93.13M |
| Employee Count | 13 |
| Asset Turnover | 0.42 |
| Inventory Turnover | 2.31 |
Taxes
In the past 12 months, UTHR has paid $353.20 million in taxes.
| Income Tax | 353.20M |
| Effective Tax Rate | 22.58% |
Stock Price Statistics
The stock price has decreased by -0.41% in the last 52 weeks. The beta is 0.57, so UTHR's price volatility has been lower than the market average.
| Beta (5Y) | 0.57 |
| 52-Week Price Change | -0.41% |
| 50-Day Moving Average | 300.20 |
| 200-Day Moving Average | 340.21 |
| Relative Strength Index (RSI) | 39.88 |
| Average Volume (20 Days) | 677,250 |
Short Selling Information
The latest short interest is 1.88 million, so 4.16% of the outstanding shares have been sold short.
| Short Interest | 1.88M |
| Short Previous Month | 2.10M |
| Short % of Shares Out | 4.16% |
| Short % of Float | 4.51% |
| Short Ratio (days to cover) | 3.83 |
Income Statement
In the last 12 months, UTHR had revenue of $2.99 billion and earned $1.21 billion in profits. Earnings per share was $25.10.
| Revenue | 2.99B |
| Gross Profit | 2.66B |
| Operating Income | 1.48B |
| Pretax Income | 1.40B |
| Net Income | 1.21B |
| EBITDA | 1.55B |
| EBIT | 1.48B |
| Earnings Per Share (EPS) | $25.10 |
Balance Sheet
The company has $3.32 billion in cash and $200.00 million in debt, giving a net cash position of $4.83 billion or $107.12 per share.
| Cash & Cash Equivalents | 3.32B |
| Total Debt | 200.00M |
| Net Cash | 4.83B |
| Net Cash Per Share | $107.12 |
| Equity (Book Value) | 6.81B |
| Book Value Per Share | 151.02 |
| Working Capital | 3.22B |
Cash Flow
In the last 12 months, operating cash flow was $1.41 billion and capital expenditures -$283.20 million, giving a free cash flow of $1.13 billion.
| Operating Cash Flow | 1.41B |
| Capital Expenditures | -283.20M |
| Free Cash Flow | 1.13B |
| FCF Per Share | $25.02 |
Margins
Gross margin is 89.00%, with operating and profit margins of 49.35% and 40.44%.
| Gross Margin | 89.00% |
| Operating Margin | 49.35% |
| Pretax Margin | 52.23% |
| Profit Margin | 40.44% |
| EBITDA Margin | 51.93% |
| EBIT Margin | 49.35% |
| FCF Margin | 37.69% |
Dividends & Yields
UTHR does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 3.02% |
| Shareholder Yield | 3.02% |
| Earnings Yield | 9.36% |
| FCF Yield | 8.72% |
Analyst Forecast
The average price target for UTHR is $393.08, which is 37.02% higher than the current price. The consensus rating is "Buy".
| Price Target | $393.08 |
| Price Target Difference | 37.02% |
| Analyst Consensus | Buy |
| Analyst Count | 13 |
| Revenue Growth Forecast (5Y) | 7.89% |
| EPS Growth Forecast (5Y) | 12.91% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on September 23, 2009. It was a forward split with a ratio of 2:1.
| Last Split Date | Sep 23, 2009 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
UTHR has an Altman Z-Score of 12.28 and a Piotroski F-Score of 7.
| Altman Z-Score | 12.28 |
| Piotroski F-Score | 7 |